Top Markets
Coin of the day
RayzeBio, Inc. Common Stock RayzeBio, Inc. Common Stock

RayzeBio, Inc. Common Stock

RYZB
Classement en actions #5676
RayzeBio, Inc. is dedicated to creating radiopharmaceutical therapies (RPTs)... RayzeBio, Inc. is dedicated to creating radiopharmaceutical therapies (RPTs) for oncology applications. Its primary therapeutic candidate, RYZ101, is currently advancing through Phase 3 clinical trials for the management of gastroenteropancreatic neuroendocrine tumors (GEP-NETs). The company's innovative pipeline also features RYZ801, a distinct peptide engineered to deliver Actinium-225 (Ac225) by targeting GPC3, intended for treating hepatocellular carcinoma (HCC). Additionally, RayzeBio is developing RYZ811, a companion diagnostic imaging agent comprising a peptide binder, a chelator, and Gallium-68 (Ga68). Another active development program involves a novel proprietary small molecule designed to target CA9, delivering Ac225 for potential use against clear cell renal cell carcinoma (ccRCC). The firm was established in 2020 and is headquartered in San Diego, California.
Prix de l'action
$62.49
Dernière synchronisation: 2024-03-06
Capitalisation boursière
$2.52B
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange RayzeBio, Inc. Common Stock (RYZB)

Catégorie

Historique des divisions d’actions pour RayzeBio, Inc. Common Stock (RYZB)
L’action RayzeBio, Inc. Common Stock (symbole : RYZB) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Aug 27, 2026.
Une action RYZB achetée avant le Aug 27, 2026 équivaudrait aujourd’hui à 0 actions RYZB.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH